Novartis to pay $347M to resolve FCPA investigations

Novartis

Novartis will pay nearly $347 million in combined criminal and civil penalty settlements with U.S. authorities to resolve all FCPA investigations into historical conduct by the company and its subsidiaries.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.